Cardiol Therapeutics Inc (CRDL)
1.99
+0.01
(+0.51%)
USD |
NASDAQ |
May 03, 16:00
1.99
0.00 (0.00%)
After-Hours: 20:00
Cardiol Therapeutics 1 Year Total Returns (Daily): 223.6% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 03, 2024 | 223.6% |
May 02, 2024 | 224.5% |
May 01, 2024 | 227.5% |
April 30, 2024 | 224.4% |
April 29, 2024 | 185.7% |
April 26, 2024 | 203.4% |
April 25, 2024 | 196.8% |
April 24, 2024 | 151.5% |
April 23, 2024 | 185.9% |
April 22, 2024 | 173.5% |
April 19, 2024 | 236.1% |
April 18, 2024 | 224.1% |
April 17, 2024 | 213.8% |
April 16, 2024 | 232.4% |
April 15, 2024 | 245.9% |
April 12, 2024 | 236.7% |
April 11, 2024 | 208.0% |
April 10, 2024 | 264.5% |
April 09, 2024 | 308.5% |
April 08, 2024 | 300.0% |
April 05, 2024 | 321.3% |
April 04, 2024 | 312.1% |
April 03, 2024 | 271.4% |
April 02, 2024 | 271.4% |
April 01, 2024 | 294.0% |
Date | Value |
---|---|
March 28, 2024 | 279.5% |
March 27, 2024 | 267.3% |
March 26, 2024 | 263.2% |
March 25, 2024 | 191.4% |
March 22, 2024 | 207.8% |
March 21, 2024 | 206.4% |
March 20, 2024 | 214.8% |
March 19, 2024 | 222.0% |
March 18, 2024 | 217.8% |
March 15, 2024 | 210.2% |
March 14, 2024 | 180.8% |
March 13, 2024 | 208.6% |
March 12, 2024 | 191.2% |
March 11, 2024 | 177.3% |
March 08, 2024 | 184.6% |
March 07, 2024 | 205.1% |
March 06, 2024 | 206.9% |
March 05, 2024 | 245.6% |
March 04, 2024 | 241.7% |
March 01, 2024 | 263.0% |
February 29, 2024 | 288.4% |
February 28, 2024 | 248.8% |
February 27, 2024 | 199.1% |
February 26, 2024 | 214.3% |
February 23, 2024 | 184.2% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-88.97%
Minimum
Oct 20 2022
321.3%
Maximum
Apr 05 2024
-4.59%
Average
-31.58%
Median
Dec 04 2020
1 Year Total Returns (Daily) Benchmarks
Aurinia Pharmaceuticals Inc | -56.37% |
Acasti Pharma Inc | 10.17% |
Edesa Biotech Inc | -40.91% |
Lexaria Bioscience Corp | 93.21% |
Xenon Pharmaceuticals Inc | 7.28% |